Original Research
Accepted on 06 May 2026
HLA-DRB3/4/5-Based Susceptibility Profiles in Nivolumab-Induced Type 1 Diabetes and Interstitial Lung Disease
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Original Research
Accepted on 06 May 2026
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Original Research
Accepted on 06 May 2026
in Veterinary Epidemiology and Economics
Case Report
Accepted on 06 May 2026
in Pediatric Surgery
Review
Accepted on 06 May 2026
in Microbial Immunology
Review
Accepted on 06 May 2026
in Environmental Health and Exposome
Original Research
Accepted on 06 May 2026
in Cancer Immunity and Immunotherapy
Review
Accepted on 06 May 2026
in Multiple Sclerosis and Neuroimmunology
Original Research
Accepted on 06 May 2026
in Antimicrobials, Resistance and Chemotherapy
Original Research
Accepted on 06 May 2026
in Food Microbiology
Original Research
Accepted on 06 May 2026
in Pediatric Neurology
Original Research
Accepted on 06 May 2026
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 06 May 2026
in Climate-Smart Food Systems
Original Research
Accepted on 06 May 2026
in Microbial Immunology
Original Research
Accepted on 06 May 2026
in Conservation and Restoration Ecology
Review
Accepted on 06 May 2026
in Cancer Immunity and Immunotherapy
Systematic Review
Accepted on 06 May 2026
in Pulmonary Medicine